SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-001454
Filing Date
2024-08-14
Accepted
2024-08-14 16:39:13
Documents
67
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mrkr-20240630x10q.htm   iXBRL 10-Q 1265566
2 EX-31.1 mrkr-20240630xex31d1.htm EX-31.1 13540
3 EX-31.2 mrkr-20240630xex31d2.htm EX-31.2 13614
4 EX-32.1 mrkr-20240630xex32d1.htm EX-32.1 6711
5 EX-32.2 mrkr-20240630xex32d2.htm EX-32.2 6376
6 GRAPHIC mrkr-20240630x10q001.jpg GRAPHIC 12637
7 GRAPHIC mrkr-20240630x10q002.jpg GRAPHIC 46872
8 GRAPHIC mrkr-20240630x10q003.jpg GRAPHIC 30612
  Complete submission text file 0001410578-24-001454.txt   5559843

Data Files

Seq Description Document Type Size
9 EX-101.SCH mrkr-20240630.xsd EX-101.SCH 40266
10 EX-101.CAL mrkr-20240630_cal.xml EX-101.CAL 31771
11 EX-101.DEF mrkr-20240630_def.xml EX-101.DEF 171761
12 EX-101.LAB mrkr-20240630_lab.xml EX-101.LAB 313477
13 EX-101.PRE mrkr-20240630_pre.xml EX-101.PRE 265418
70 EXTRACTED XBRL INSTANCE DOCUMENT mrkr-20240630x10q_htm.xml XML 771027
Mailing Address 2450 HOLCOMBE BLVD SUITE BCM-A, MS: BCM251 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE BCM-A, MS: BCM251 HOUSTON TX 77021 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37939 | Film No.: 241208868
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)